Table 3 Distribution of second-line drug resistance amongst the patient variables
Variable | % Proportion (95% Confidence interval) | |||
|---|---|---|---|---|
FQ Only (n = 42) | IA Only (n = 12) | FQ/IA (n = 54) | FQ & IA (n = 14) | |
Age groups | ||||
< 35 years | 64.3 (48.0–78.4) | 83.3 (51.6–97.9) | 59.3 (45.0–72.4) | 85.7 (57.2–98.2) |
≥ 35 years | 35.7 (21.6–52.0) | 16.7 (2.1–48.4) | 40.7 (27.6–55.0) | 14.3 (1.8–42.8) |
Gender | ||||
Female | 23.8 (12.1–39.4) | 25.0 (5.5–57.4) | 11.1 (4.2–22.6) | 35.7 (12.8–64.9) |
Male | 76.2 (60.5–87.9) | 75.0 (42.8–94.5) | 88.9 (77.4–95.8) | 64.3 (35.1–87.2) |
History of TB treatment | ||||
Previously treated | 64.3 (48.0–78.4) | 66.7 (34.9–90.1) | 59.3 (45.0–72.4) | 71.4 (41.9–91.6) |
New case | 33.3 (19.6–49.5) | 33.3 (10.0–65.1) | 38.9 (25.9–53.1) | 28.6 (8.4–58.1) |
Treatment history unknown | 0 (0.0) | 0 (0.0) | 0 (0.0) | 0 (0.0) |
Not provided | 2.4 (0.1–12.6) | 0 (0.0) | 1.9 (0.0–9.9) | 0 (0.0) |